August, 19

India Commences Administering Free COVID-19 Jab For Adults

All adults in India will begin receiving covid-19 free booster doses on Friday.

To commemorate the nation’s independence day on August 15—the 75th anniversary—the drive will continue for 75 days.

Before this, only frontline employees, health professionals, and individuals over 60 years old were qualified for free booster doses. It was a cost borne by others.

A few days prior, India changed the interval between the second and third doses of the vaccine from nine months to six months.

The announcement is anticipated to increase the country’s coverage of the booster dose, or precaution dose as it is known in India.

According to a Thursday article in the Hindustan Times newspaper, 92% of Indians who qualified for a booster dose haven’t yet received one.

India has only given 50 million booster doses—about 5% of the eligible population—so far.

The nation launched the booster dose program in January for frontline healthcare personnel, people over 60, and people with comorbidities.

Later, it made the drive available to all adults. A vaccination program for teenagers aged 15 to 18 started in January, and one for children aged 12 to 14 in March.

Since the country’s immunization campaign got underway in January 2021, more than 1.99 billion doses have been given out.

India has so far reported about 43.5 million cases of COVID, second only to the US, and nearly 525,000 fatalities, third only to the US and Brazil.

The number of cases being reported in the nation each day is currently at 16,000; over the previous several weeks, states like Maharashtra, Kerala, Tamil Nadu, and West Bengal have observed an increase in the number of daily active cases. The federal government has requested that states increase their viral surveillance, including random screening of international travelers.

When immunizations were made available to 960 million eligible people in January 2021, the rollout in India got off to a delayed start.

The implementation was hampered by logistical issues, supply shortages, vaccine reluctance, and a crippling second wave of Covid-19 during this time.

However, when things stabilized, it was able to increase coverage, with the vaccine being provided by tens of thousands of public and commercial health facilities.

Drones were used to provide immunizations to remote villages in the mountainous regions of northeast India.

Additionally, doses were transported by drones to the eastern archipelago of Andamans, and Nicobar were “boat transportation” proved cumbersome.

The initiative has achieved certain objectives, while missing its initial, overly ambitious goal for adult vaccination, which was the 31st of December 2021.

To celebrate Prime Minister Narendra Modi’s 71st birthday on September 17, India broke its record by dispensing more than 20 million pills in a single day.

It passed the one billion thresholds in October, becoming the second nation behind China to do so.

What vaccinations does India use?

India presently uses four vaccines: the Oxford-AstraZeneca shot, locally known as Covishield; Covaxin, developed by the Indian company Bharat Biotech; Sputnik V, made by Russia; and Corbevax, made by Belarus.

Up to this point, Covishield has been responsible for almost 80% of doses given to adults.

The Indian medicines regulator granted emergency use authorization for Corbevax, a protein-based vaccine produced by Biological E, in February 2022 for the 12- to 18-year-old age range.

The Serum Institute of India’s Covovax medication was permitted in June for limited emergency usage in kids between the ages of seven and twelve.

The vaccine from Moderna, which has demonstrated nearly 95% efficacy against Covid-19, was also authorized for import by the government by the Indian pharmaceutical company Cipla. But India hasn’t yet received any of these dosages.

It also authorized Sputnik Light, a brand-new single-dose vaccine that is a part of Sputnik V, in February.

Has vaccination caused any “adverse events”?

Vaccines can have unintended effects on people.

India has had a surveillance scheme in place to track “adverse events” following immunization for three decades. According to experts, failing to transparently report such events could cause misinformation about vaccines.

The administration informed the Supreme Court that as of March 13, 2022, the nation had documented more than 772,000 “adverse events” related to vaccinations. “Minor, serious, and severe events” were covered in this.

The number of critical situations, when immunizations may or may not be the cause of death, was “minuscule.”

The danger of dying after immunization is tiny compared to the known risk of dying from Covid-19 disease, the government has previously stated, adding that unpleasant reactions may not always be brought on by the vaccines.

Uchara Faith
Faith is a valiant writer who has an undisputed passion for writing. She has worked with many highly reputable companies as content creator, radio presenter. She has a book to her name titled ECHO OF A DISTRESSED HEART. She's goal driven oriented person.

Get in Touch

Get in Touch


Latest Posts